Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely
Sex and gender aspects are gaining attention in oncology. Epidemiological studies show that women have reduced risk and better outcome than men in a wide range of cancer types. Melanoma is a prime example of cancer with significant female survival advantage across different stages and independent of...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2020-10-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/hbT.OH.2020.05.21 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850257091284959232 |
|---|---|
| author | Berna C. Özdemir Anna Dorothea Wagner |
| author_facet | Berna C. Özdemir Anna Dorothea Wagner |
| author_sort | Berna C. Özdemir |
| collection | DOAJ |
| description | Sex and gender aspects are gaining attention in oncology. Epidemiological studies show that women have reduced risk and better outcome than men in a wide range of cancer types. Melanoma is a prime example of cancer with significant female survival advantage across different stages and independent of various prognostic factors. In addition, accumulating evidence shows that women are more susceptible to the toxicity of different types of drugs. Also, considering their differences in body composition, sex-specific dosing strategies, taking into account a patient’s fat-free body mass could improve the balance between efficacy and toxicity of anticancer therapies in men and women. |
| format | Article |
| id | doaj-art-828def346511475c846a5e58be423cff |
| institution | OA Journals |
| issn | 2673-2092 2673-2106 |
| language | English |
| publishDate | 2020-10-01 |
| publisher | THE HEALTHBOOK COMPANY LTD. |
| record_format | Article |
| series | healthbook TIMES. Oncology Hematology |
| spelling | doaj-art-828def346511475c846a5e58be423cff2025-08-20T01:56:29ZengTHE HEALTHBOOK COMPANY LTD.healthbook TIMES. Oncology Hematology2673-20922673-21062020-10-015310.36000/hbT.OH.2020.05.21Precision Oncology and Gender Medicine – Moving Forward, Slowly but SurelyBerna C. ÖzdemirAnna Dorothea WagnerSex and gender aspects are gaining attention in oncology. Epidemiological studies show that women have reduced risk and better outcome than men in a wide range of cancer types. Melanoma is a prime example of cancer with significant female survival advantage across different stages and independent of various prognostic factors. In addition, accumulating evidence shows that women are more susceptible to the toxicity of different types of drugs. Also, considering their differences in body composition, sex-specific dosing strategies, taking into account a patient’s fat-free body mass could improve the balance between efficacy and toxicity of anticancer therapies in men and women.https://doi.org/10.36000/hbT.OH.2020.05.21 |
| spellingShingle | Berna C. Özdemir Anna Dorothea Wagner Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely healthbook TIMES. Oncology Hematology |
| title | Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely |
| title_full | Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely |
| title_fullStr | Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely |
| title_full_unstemmed | Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely |
| title_short | Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely |
| title_sort | precision oncology and gender medicine moving forward slowly but surely |
| url | https://doi.org/10.36000/hbT.OH.2020.05.21 |
| work_keys_str_mv | AT bernacozdemir precisiononcologyandgendermedicinemovingforwardslowlybutsurely AT annadorotheawagner precisiononcologyandgendermedicinemovingforwardslowlybutsurely |